Home » Topics » Regulatory » EMA

EMA
RSS

Novartis withdraws application to extend marketing authorization for Zometa

Nov. 22, 2007

MSD's Isentress for HIV-1 infection gets positive opinion from CHMP

Nov. 21, 2007

CHMP recommends Merck, Sharp and Dohme's Ivemend for nausea with chemotherapy

Nov. 21, 2007

Abbott voluntarily withdraws E.U. marketing authorization for Trudexa

Aug. 1, 2007

Bausch & Lomb Ireland withdraws Retisert marketing authorization application

July 27, 2007

Rasilez recommended for E.U. approval

June 25, 2007

Orlistat GSK recommended for approval in E.U.

June 1, 2007

Protherics withdraws European application for Voraxaze

May 31, 2007

European CHMP recommends approval of Siklos

May 10, 2007

Pergoveris recommended for E.U. approval

May 9, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...